This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: The Innovations of Hans Jacob Hager
Introduction
Hans Jacob Hager is an accomplished inventor based in New York, NY. He has made significant contributions to the field of diagnostics, particularly in the detection of opium alkaloids. His innovative approach has led to the development of a unique diagnostic test that is both sensitive and effective.
Latest Patents
Hager holds a patent for a diagnostic test for opium alkaloids. This patent involves amino lower alkyl ethers of the phenolic hydroxyl group of opium alkaloids, which are linked via a peptide linkage to carboxylated latex polymers. These reagents are instrumental in detecting the presence of opium alkaloids in body fluids, showcasing Hager's expertise in the field.
Career Highlights
Hager is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has allowed him to focus on innovative solutions in diagnostics, contributing to advancements in medical technology.
Collaborations
Hager has collaborated with Roy Cleeland, Jr., further enhancing his research and development efforts. Their partnership has been pivotal in driving forward the innovations in diagnostic testing.
Conclusion
Hans Jacob Hager's contributions to the field of diagnostics, particularly through his patent for detecting opium alkaloids, highlight his role as a significant inventor. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile